Private Equity

  • April 22, 2026

    4 Firms Build Amneal's Up To $1.1B Kashiv Biosimilars Buy

    Biopharmaceutical company Amneal Pharmaceuticals Inc. on Wednesday unveiled plans to acquire biosimilars-focused Kashiv BioSciences LLC in a deal worth up to $1.1 billion that was built by four law firms.

  • April 22, 2026

    Willkie Helps Mutares Raise €105M For US Expansion

    German private equity shop Mutares said Wednesday that it has raised €105 million ($123 million) to fuel its expansion in the U.S. through acquisitions.

  • April 21, 2026

    Armistice Capital Head Calls COVID Stock Rise 'Fun,' 'Lucky'

    Armistice Capital's founder defended his hedge fund Tuesday from claims it pump-and-dumped $250 million in Vaxart stock during the COVID-19 pandemic, telling a California federal jury that he and his fund got "lucky" and that the stock's rapid surge was "fun."

  • April 21, 2026

    Jury Told Ex-Finance CEO Is The Fall Guy In $100M Fraud Case

    Counsel for the founder of Beneficient on Tuesday told a Manhattan federal jury that the founder of the Dallas-based financial services firm did not defraud its onetime business partner GWG Holdings out of more than $100 million, saying a group of former insiders are trying to scapegoat the executive for GWG's downfall.

  • April 21, 2026

    Biotech Co. Investors Clash Over 'Self-Dealing' Claim

    Attorneys for a biopharmaceutical and technology company stockholder and a group of venture investors sharply disagreed Tuesday over whether a financing deal was a lifeline for a struggling company or a self-serving maneuver that enriched insiders, as they argued a motion to dismiss the derivative suit in the Delaware Chancery Court.

  • April 21, 2026

    Del. Supreme Court Upholds Ruling On Truth Social Shares

    The Delaware Supreme Court has affirmed a lower court ruling granting additional stock to the founding shareholder in the company that took President Donald Trump's Truth Social Media public, turning away a request from the shareholder for a second shot to prove it is owed even more shares.

  • April 21, 2026

    Buyer Sues PE Firm, Alleging Fraud In $26M Manufacturer Sale

    A Michigan-based buyer has sued a private equity firm and two executives in Delaware's Court of Chancery, accusing them of orchestrating a yearslong scheme to inflate a manufacturing company's value and fraudulently induce a $26 million sale.

  • April 21, 2026

    Latham, Loeb Guide AI Battery Co.'s $250M SPAC Merger

    Electra Vehicles Inc., a provider of artificial intelligence-driven battery technology that is represented by Latham & Watkins LLP, outlined Tuesday its plans to go public by merging with a special purpose acquisition company advised by Loeb & Loeb LLP, in a deal valued at more than $250 million.

  • April 21, 2026

    3 Firms Guide $1.2B Semiconductor Equipment SPAC Deal

    U.S.-based semiconductor materials company Forge Nano said Tuesday it has agreed to combine with blank check company Archimedes Tech SPAC Partners II Co. in a deal that values Forge Nano at $1.2 billion.

  • April 21, 2026

    HarbourVest Wraps 13th Fund With $2.4B In Tow

    Boston-based private equity shop HarbourVest Partners, advised by Debevoise & Plimpton LLP, on Tuesday revealed that it closed its 13th U.S. flagship primary fund after securing $2.4 billion in total capital commitments.

  • April 21, 2026

    EQT Raises $15.6B For Asia-Pacific Private Equity Fund

    EQT AB said Tuesday that it has raised $15.6 billion for a fund that will give investors in the Swedish private equity firm access to technology and healthcare companies in the Asia-Pacific region.

  • April 20, 2026

    Armistice Head Testifies He Accidentally Deleted Texts

    Armistice Capital's founder, who is facing investor claims that the hedge fund dumped its artificially inflated shares in pharmaceutical company Vaxart for $250 million, told a California federal jury Monday that during a physical therapy session held over Skype, he accidentally deleted key text messages with another Armistice executive.

  • April 20, 2026

    SEC, CFTC Propose Rules To Relax Private Fund Reporting

    The U.S. Securities and Exchange Commission on Monday proposed relaxing certain reporting requirements for hedge funds and other private fund advisers by allowing smaller firms to forego filing a disclosure used to monitor systemic risk and nixing some of its questions around volatility, event reporting and indirect exposure altogether.

  • April 20, 2026

    Kirkland-Led Cerberus Closes $2.3B Continuation Fund

    Kirkland & Ellis LLP-advised Cerberus Capital Management on Monday announced that it closed its latest single-asset continuation vehicle after securing $2.3 billion in commitments, which will allow the private equity firm to continue to own a controlling stake in critical digital infrastructure company Subsea Communications.

  • April 20, 2026

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court this past week delivered another mix of procedural rulings, fiduciary duty disputes and deal litigation, highlighting both the court's gatekeeping role and its continued focus on stockholder rights and transactional fairness.

  • April 20, 2026

    Justices Cast Doubt On Effort To Limit SEC Disgorgement

    The U.S. Supreme Court on Monday questioned an attempt to limit the U.S. Securities and Exchange Commission's disgorgement powers, with conservative and liberal justices alike seemingly skeptical of the argument that the agency has to identify victims before it can demand the return of ill-gotten gains.

  • April 20, 2026

    Kirkland, Goodwin Guide Lilly's Potential $7B Kelonia Buy

    Kirkland & Ellis LLP-advised pharmaceutical giant Eli Lilly & Co. on Monday announced plans to acquire clinical-stage biotechnology company Kelonia Therapeutics, led by Goodwin Procter LLP, in a deal worth up to $7 billion.

  • April 20, 2026

    4 Firms Guide $1.4B Honeywell, Brady Productivity Unit Deal

    Honeywell said Monday that it has agreed to sell its productivity solutions and services business to Brady Corp. as the company nears the completion of a multiyear portfolio transformation, with four law firms advising. 

  • April 20, 2026

    Justices Won't Review Vegas Hotel Algorithmic Pricing Suit

    The U.S. Supreme Court on Monday rejected a petition seeking to revive a proposed class action accusing casino-hotel operators on the Las Vegas Strip of using software from Cendyn Group to illegally inflate room rates.

  • April 17, 2026

    'Constantly Shifting': Judge Rips Musk, OpenAI As Trial Nears

    A California federal judge Friday appeared frustrated with Elon Musk and OpenAI ahead of trial over Musk's challenge to OpenAI's conversion to a for-profit entity, criticizing the parties' "constantly shifting" positions and doubting whether she has the authority to grant the relief Musk requested.

  • April 17, 2026

    Drone Co. Aevex Joins Defense-Related IPOs, Raising $320M

    Drone-maker Aevex Corp. began trading Friday after raising $320 million in its initial public ‌offering, steered by a Kirkland & Ellis LLP team and with Latham & Watkins LLP advising the underwriters.

  • April 17, 2026

    NorthStar Inks $300M SPAC Deal As Space Debris Risk Rises

    NorthStar Earth & Space said Friday it will merge with a blank-check company in a deal valuing NorthStar at $300 million, as the Canadian company bets that increasingly congested orbits will require continuous monitoring to avoid collisions and service disruptions.

  • April 17, 2026

    Macquarie Selling Romanian Grid Network For About $825M

    Premier Energy Group said Friday it has agreed to acquire Romania-based electricity distributor Distributie Energie Oltenia, or DEO, from funds managed by Australia's Macquarie Asset Management for about €700 million ($825 million).

  • April 17, 2026

    Reed Smith Lands McDermott Fund Finance Pro In Miami

    Reed Smith LLP has added a partner in Miami from McDermott Will & Schulte LLP to bolster its capacity to advise clients about fund finance and private capital matters.

  • April 17, 2026

    Latham Leads Kailera's $625M IPO In Obesity Drug Push

    Obesity biotech Kailera Therapeutics made its public debut Friday, raising $625 million in an upsized initial public offering that represents one of the largest biotech IPOs in recent years.

Expert Analysis

  • Series

    Writing Musicals Makes Me A Better Lawyer

    Author Photo

    My experiences with writing musicals and practicing law have shown that the building blocks for both endeavors are one and the same, because drama is necessary for the law to exist, says Addison O’Donnell at LOIS Law.

  • Series

    Adapting To Private Practice: From Va. AUSA To Mid-Law

    Author Photo

    Returning to the firm where I began my career after seven years as an assistant U.S. attorney in Virginia has been complex, nuanced and rewarding, and I’ve learned that the pursuit of justice remains the constant, even as the mindset and client change, says Kristin Johnson at Woods Rogers.

  • 7 Document Review Concepts New Attorneys Need To Know

    Author Photo

    For new associates joining firms this fall, stepping into the world of e-discovery can feel like learning a new language, but understanding a handful of fundamentals — from coding layouts to metadata — can help attorneys become fluent in document review, says Ann Motl at Bowman and Brooke.

  • Agentic AI Puts A New Twist On Attorney Ethics Obligations

    Author Photo

    As lawyers increasingly use autonomous artificial intelligence agents, disciplinary authorities must decide whether attorney responsibility for an AI-caused legal ethics violation is personal or supervisory, and firms must enact strong policies regarding agentic AI use and supervision, says Grace Wynn at HWG.

  • Sweeping US Tax And Spending Bill May Bolster PE Returns

    Author Photo

    The One Big Beautiful Bill Act stands to benefit private equity sponsors and their investors as it alters existing law, including at the portfolio company level, making it crucial to reevaluate historic tax planning and optimize for the new tax regime, say attorneys at Paul Hastings.

  • Series

    Being A Professional Wrestler Makes Me A Better Lawyer

    Author Photo

    Pursuing my childhood dream of being a professional wrestler has taught me important legal career lessons about communication, adaptability, oral advocacy and professionalism, says Christopher Freiberg at Midwest Disability.

  • SEC Rulemaking Radar: The Debut Of Atkins' 'New Day'

    Author Photo

    The U.S. Securities and Exchange Commission's regulatory flex agenda, published last week, demonstrates a clear return to appropriately tailored and mission-focused rulemaking, with potential new rules applicable to brokers, exchanges and trading, among others, say attorneys at Goodwin.

  • Series

    Law School's Missed Lessons: Adapting To The Age Of AI

    Author Photo

    Though law school may not have specifically taught us how to use generative artificial intelligence to help with our daily legal tasks, it did provide us the mental building blocks necessary for adapting to this new technology — and the judgment to discern what shouldn’t be automated, says Pamela Dorian at Cozen O'Connor.

  • Ch. 11 Ruling Voiding $2M Litigation Funding Sends A Warning

    Author Photo

    A recent Texas bankruptcy court decision that a postconfirmation litigation trust has no obligations to repay a completely drawn down $2 million litigation funding agreement serves as a warning for estate administrators and funders to properly disclose the intended financing, say attorneys at Kleinberg Kaplan.

  • What To Expect As Trump's 401(k) Order Materializes

    Author Photo

    Following the Trump administration’s recent executive order on 401(k) plan investments in alternative assets like cryptocurrencies and real estate, the U.S. Department of Labor and the U.S. Securities and Exchange Commission will need to answer several outstanding questions before any regulatory changes are implemented, say attorneys at Cleary.

  • Demystifying The Civil Procedure Rules Amendment Process

    Author Photo

    Every year, an advisory committee receives dozens of proposals to amend the Federal Rules of Civil Procedure, most of which are never adopted — but a few pointers can help maximize the likelihood that an amendment will be adopted, says Josh Gardner at DLA Piper.

  • With Obligor Ruling, Ohio Justices Calm Lending Waters

    Author Photo

    A recent decision by the Ohio Supreme Court, affirming a fundamental principle that lenders have no duty to disclose material risks to obligors, provides clarity for commercial lending practices in Ohio and beyond, and offers a reminder of the risks presented by guarantee arrangements, says Carrie Brosius at Vorys.

  • Evaluating The SEC's Rising Whistleblower Denial Rate

    Author Photo

    The rising trend of U.S. Securities and Exchange Commission whistleblower award claim denials represents a departure from the SEC's previous track record and may reflect a more conservative approach to whistleblower award determinations under the current administration, say attorneys at Troutman Pepper.

  • Parenting Skills That Can Help Lawyers Thrive Professionally

    Author Photo

    As kids head back to school, the time is ripe for lawyers who are parents to consider how they can incorporate their parenting skills to build a deep, meaningful and sustainable legal practice, say attorneys at Alston & Bird.

  • Unpacking The New Opportunity Zone Tax Incentive Program

    Author Photo

    The One Big Beautiful Bill Act brought several improvements to the opportunity zone tax incentive program that should boost investments in qualified funds, including making it permanent, increasing federal income tax benefits in rural areas, redesignating the qualified zones, and requiring more in-depth reporting, says Marc Schultz at Snell & Wilmer.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Private Equity archive.